Laxmi Organic Q1 FY26 Earnings Results

Laxmi Organic Industries Limited was established in 1989 and is in the business of specialty chemicals. The Company primarily manufactures Ethyl Acetate, Acetic Acid and Diketene Derivative Products (DDP). DDP is a specialty chemical group, the technology and business of which has been acquired by the company from Clariant Chemicals India Limited. The company’s business operations are carried in over 30 countries including 11 offices located in India. Presenting below are its Q1 FY26 earnings results.

 

Q1 FY26 Earnings Results

• Total Income: ₹693 crores, down 3.4% YoY (Q1 FY25: ₹718 crores), down 12.7% QoQ (Q4 FY25: ₹710 crores).

• Total Expenses: ₹662 crores, up 1.18% YoY, down 6.5% QoQ.

• Profit Before Tax (PBT): ₹14.19 crores, down 73.7% YoY (Q1 FY25: ₹53.98 crores), down 79.1% QoQ (Q4 FY25: ₹67.99 crores).

• Profit After Tax (PAT): ₹21.39 crores, down 38.2% YoY (Q1 FY25: ₹34.35 crores), down 51.7% QoQ (Q4 FY25: ₹44.30 crores).

• Earnings Per Share (EPS): ₹0.77, down 37.9% YoY (Q1 FY25: ₹1.20).

• EBITDA: ₹30.8 crores, down 57% YoY (Q1 FY25: ₹71.2 crores); EBITDA margin: 4.4% vs. 9.9% YoY.

• Segment Performance:

  • Essentials segment revenue: ₹485.8 crores, up 4% YoY; segment volumes up 11%, but acetic acid prices declined.

  • Specialties segment revenue: ₹207.1 crores, down 18% YoY, impacted by phase-out of agro product and delivery deferments.

• Volume Growth: Overall volumes grew by 8% YoY.

• Major Projects: Lote fluorine intermediates ramping up; Dahej project on track to begin commercial operations in Q2 FY26.

• Management View: Focus remains on cost optimization, product mix improvement, supply chain digitization, and ramping up new projects.

 

Management Commentary & Strategic Highlights

• The quarter saw soft demand in key markets and pricing headwinds, especially for acetic acid, limiting revenue gains despite volume growth.

• Strategic investments in new facilities and diversification into personal care/power transmission are expected to support improved performance in H2/FY27.

• Management guided for Q2 performance to be similar or slightly better, with specialties expected to recover in the second half of FY26.

• Timely execution and cost controls remain critical as market dynamics evolve.

 

 

Q4 FY25 Earnings Results

• Total Income: ₹710 crores.

• Profit After Tax (PAT): ₹22 crores.

• EBITDA: ₹59 crores; EBITDA margin: 8.3%.

 

To view the company’s previous earnings and latest concall transcripts, click here  to visit the Alphastreet India news channel.